CABALETTA BIO INC (CABA) Forecast, Price Target & Analyst Ratings

NASDAQ:CABA • US12674W1099

Current stock price

2.94 USD
-0.1 (-3.29%)
At close:
3.03 USD
+0.09 (+3.06%)
Pre-Market:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CABALETTA BIO INC (CABA).

Forecast Snapshot

Consensus Price Target

Price Target
$13.39
+ 355.36% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 30, 2026
Period
Q4 / 2025
EPS Estimate
-$0.47
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
83.75%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$13.39
Upside
+ 355.36%
From current price of $2.94 to mean target of $13.39, Based on 16 analyst forecasts
Low
$2.02
Median
$14.28
High
$31.50

Price Target Revisions

1 Month
0.00%
3 Months
-7.08%

Price Target Summary

16 Wall Street analysts provided a forecast for the next 12 months for CABA. The average price target is 13.39 USD. This implies a price increase of 355.36% is expected in the next year compared to the current price of 2.94.
The average price target has been revised downward by 7.08% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CABA Current Analyst RatingCABA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

CABA Historical Analyst RatingsCABA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
83.75%
CABA was analyzed by 16 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about CABA.
In the previous month the buy percentage consensus was at a similar level.
CABA was analyzed by 16 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-10-31Cantor FitzgeraldMaintains Overweight -> Overweight
2025-10-10HC Wainwright & Co.Reiterate Buy -> Buy
2025-09-05Cantor FitzgeraldReiterate Overweight -> Overweight
2025-08-08Wells FargoMaintains Equal-Weight -> Equal-Weight
2025-06-11HC Wainwright & Co.Reiterate Buy -> Buy
2025-05-16GuggenheimMaintains Buy -> Buy
2025-05-16CitigroupMaintains Buy -> Buy
2025-05-15GuggenheimMaintains Buy -> Buy
2025-04-01GuggenheimReiterate Buy -> Buy
2025-04-01UBSMaintains Buy -> Buy
2025-04-01Wells FargoMaintains Equal-Weight -> Equal-Weight
2025-04-01Morgan StanleyMaintains Overweight -> Overweight
2025-04-01HC Wainwright & Co.Reiterate Buy -> Buy
2025-02-18HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-17HC Wainwright & Co.Reiterate Buy -> Buy
2024-12-20Evercore ISI GroupDowngrade Outperform -> In-Line
2024-12-19Wells FargoDowngrade Overweight -> Equal-Weight
2024-11-18HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-15Wells FargoMaintains Overweight -> Overweight
2024-11-15HC Wainwright & Co.Reiterate Buy -> Buy
2024-10-10UBSInitiate Buy
2024-09-17HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-12Wells FargoMaintains Overweight -> Overweight
2024-08-12Evercore ISI GroupMaintains Outperform -> Outperform
2024-08-09HC Wainwright & Co.Maintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 30, 2026
Period
Q4 / 2025
EPS Estimate
-$0.47
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
27.07%
Number of Analysts
11

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

CABA is expected to report earnings on 3/30/2026. The consensus EPS estimate for the next earnings is -0.47 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CABA revenue by date.CABA revenue by date.
N/AN/AN/AN/AN/A
326.08%		N/A
91.11%		N/A
65.07%		N/A
16.82%		N/A
-30.32%
EBITDA
YoY % growth
CABA ebitda by date.CABA ebitda by date.
N/AN/A-18.58M-33.48M
-80.19%		-45.58M
-36.14%		-52.96M
-16.19%		-73.234M
-38.28%		-120.328M
-64.31%		N/A
-50.61%		N/A
-14.36%		N/A
-12.13%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
CABA ebit by date.CABA ebit by date.
-250K-6.19M
-2,376.00%		-18.68M
-201.78%		-33.83M
-81.10%		-46.31M
-36.89%		-54.14M
-16.91%		-74.66M
-37.90%		-125.141M
-67.61%		N/A
-45.65%		N/A
-11.51%		N/A
-18.67%		N/A
8.31%		N/A
88.10%		N/A
1,253.42%		N/A
318.01%		N/A
24.11%		N/A
-50.72%
Operating Margin
CABA operating margin by date.CABA operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
CABA eps by date.CABA eps by date.
N/AN/AN/A-1.44
68.09%		-1.80
-25.00%		-1.81
-0.56%		-1.65
8.84%		-2.34
-41.82%		N/A
7.13%		N/A
16.70%		N/A
0.26%		N/A
24.86%		N/A
75.69%		N/A
429.94%		N/A
417.48%		N/A
19.57%		N/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.47
27.07%		-0.43
39.72%		-0.48
34.85%		-0.42
3.42%		-0.43
8.91%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		-50.541M
-74.45%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-50.1M
-48.29%		-48.042M
-29.37%		-51.102M
-12.30%		-52.352M
-12.37%		-53.933M
-7.65%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CABA Yearly Revenue VS EstimatesCABA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
CABA Yearly EPS VS EstimatesCABA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4 -4 6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
7.10%
EPS Next 5 Year
13.20%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-21.95%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CABALETTA BIO INC / CABA Forecast FAQ

What is the average price target for CABALETTA BIO INC (CABA) stock?

16 analysts have analysed CABA and the average price target is 13.39 USD. This implies a price increase of 355.36% is expected in the next year compared to the current price of 2.94.

When does CABALETTA BIO INC (CABA) report earnings?

CABALETTA BIO INC (CABA) will report earnings on 2026-03-30, after the market close.

What are the consensus estimates for CABALETTA BIO INC (CABA) next earnings?

The consensus EPS estimate for the next earnings of CABALETTA BIO INC (CABA) is -0.47 USD and the consensus revenue estimate is 0 USD.

How many analysts have analysed CABALETTA BIO INC (CABA)?

The number of analysts covering CABALETTA BIO INC (CABA) is 16.